Objective: To evaluate whether frontal-lobe magnetic resonance spectroscopy measures of g-aminobutyric acid (GABA) would be altered in a sample of adolescents scanned after sport concussion because mild traumatic brain injury is often associated with working memory problems.
Traumatic brain injury has been the subject of extensive MRI study over the past 20 years. While much of this work has focused on moderate and severe injury as defined by Glasgow Coma Scale score on admission, a growing literature focuses on milder traumatic brain injury defined as Glasgow Coma Scale score .13 to 15 with no loss of consciousness caused by sport mechanisms. 1 Indeed, many new studies now focus on the most mild spectrum of injury, often called exposure. 2 In sport terms, this is defined as the potential, counted, or measured head blows (e.g., football participation, soccer heading, sensor triggering) without necessitating a diagnosis of concussion. 3 Although this injury category of risk represents the goal state for defining injury at its subtlest manifestation, the potential for outliers driving generalizations 4 and whether head injury rotational mechanics can be adequately quantified via sensor technologies 5 remain work for further optimization. Commonly used imaging techniques of brain injury focus on structural or connectivity measures 6 and task-based fMRI used to look at known vulnerable systems such as working memory. 7 A growing body of literature outside traumatic injury aims to integrate fMRI and neurotransmitter results, with a focus on g-aminobutyric acid (GABA) because of its measurement specificity. To evaluate the utility of this measure in children diagnosed with concussion and having persistent symptoms at clinic visit, we enrolled a pilot cohort of children with concussion compared with age-and sex-matched healthy controls. presented at a rate of 2 seconds on a liquidcrystal display screen that was visible via a mirror mounted on a head coil. Left frontal lobe activation was identified from activation vs rest blocks (30 seconds) with maps generated in real time. Participants responded to the task via button press with the right hand denoting correct or incorrect response. These responses and latencies were written to a text file for offline analyses. Two spectroscopy acquisitions followed fMRI: one localized in left frontal lobe as guided by the activation map generated from the working memory task and displayed on the scanner, and another placed in the central posterior cingulate cortex. Both acquisitions used MEGA-PRESS (Siemens Medical Systems, Malvern, PA) with a 3 3 3 3 3-cm voxel, TE of 68 milliseconds (with and without frequency selection), TR of 2,000 milliseconds, and 128 averages. Lastly, resting-state fMRI with eyes open was collected at slice positions similar to the task-based scan and slightly varying parameters (TE 27 milliseconds, TR 2,000 milliseconds, 33 interleaved slices, 192 acquisitions).
METHODS
Analyses. MRIs were reviewed clinically by the study radiologist (D.W.S.). Automated processing of MEGA-PRESS data was done by Gannet. 9 Magnetic resonance spectroscopy (MRS) data with off-resonance editing were processed in LCModel 10 to generate non-GABA metabolite estimates. To measure the gray/ white ratio underlying each measurement, T1 images were segmented in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/ spm8/; UCL, London, UK) and masked by the spectral voxel location extracted from the raw spectral file with MATLAB (Mathworks, Natick, MA). Automated summation of pixels for each tissue class yielded gray/white ratio data. These masks were also multiplied by fMRI working memory activation maps and summarized to yield measures of median activation. DTI data were analyzed in batch in FSL (http://fsl.fmrib.ox.ac.uk/), and resting-state FMRI data were analyzed with CONN (https:// www.nitrc.org/projects/conn/) as per our prior work. 11, 12 Statistics. Paired parametric statistics were compared for GABA/ creatine 1 phosphocreatine (Cre), gray/white fraction, and task performance. Regression analyses were performed to compare the association between GABA and median voxel fMRI task activation. Output maps from FSL (DTI) and CONN (resting fMRI) were examined for significant effects at p , 0.05 corrected for multiple comparisons without a priori masking. Exploratory analyses were performed for other MRS metabolites and neuropsychological testing data.
RESULTS One control had missing data because of claustrophobia, precluding MRI scanning, and 1 had missing latency performance data as a result of computer malfunction. One concussed patient's data were excluded because of motion artifact on MRI data and MRS failure. This yielded 10 (5 male, 5 female) participants per group. The clinic visit occurred 12 6 8 days (minimum 5 2, maximum 5 28) after injury, with Sport Concussion Assessment Tool 3 symptoms ranging from 10 to 88 (mean 48 6 25, maximum 5 132). Symptoms described in the chart notes for the concussed group were headaches (10 of 10), feeling in a fog (6 of 10), difficulty concentrating (9 of 10), confusion (6 of 10), and fatigue (8 of 10). MRI examination occurred at a mean of 18 days (SD 7, minimum 8, maximum 29 days) after the clinic visit. Measured from the date of injury, MRIs occurred for the group at a group recovery time point of z1 month (mean 30.4 6 6.1, minimum 5 23, maximum 5 44 days).
MRI study. No structural abnormalities, including any suggestive of traumatic brain injury (e.g., diffusion alterations, punctate hemorrhage, gliosis), were observed on the structural imaging scans.
During the fMRI working memory scan, task percent correct and latency of response did not differ between groups (table) . For spectroscopy data, no statistical differences were observed for Gannet fit error or gray/white voxel fractions by anatomic Exploratory analyses of choline-containing compounds, N-acetylaspartate, or glutamate referenced to Cre in the off-resonance spectrum demonstrated no differences for any metabolite by group (all t , 1.18 and .21.4, p . 0.2). A similar lack of group differences was shown for the DTI data (measures of fractional anisotropy and mean diffusivity) by tractbased spatial statistics in FSL, resting-state fMRI connectivity matrices in CONN, and neuropsychological test scores in the subgroups receiving testing (all p . 0.05 corrected for multiple comparisons). DISCUSSION In this pilot sample of teenagers with first-time concussions and persisting symptoms, frontal lobe GABA levels were elevated 1 month after injury. Supportive of this finding, the normally consistent relationship between GABA and working memory fMRI activation seen in the control group was disrupted. In contrast, decreased GABA was seen in medial parietal areas for the concussed group, a system that has broad functional implications for connectivity. Ascribing a theoretical basis to the direction of change is challenging. What we are seeing at this single postacute time point could be directly related to injury, recovery (a responsive change), or a mixture thereof, none of which can be discriminated without further longitudinal data. In terms of clinical relevance, GABA/Cre alterations after concussion could help to measure the arc of injury and recovery. Evaluating such measures in the context of "return to learn," cognitive rest, or symptom resolution will be exciting avenues to explore in future work. GABA is the major inhibitory neurotransmitter and is an important factor in both normal cognitive function and the sequelae of traumatic brain injury. 13 While spectroscopy has now been widely applied in traumatic brain injury, primarily to look for markers of neuronal loss before the development of DTI 14 (for review, see reference 15), to the best of our knowledge, no study to date has evaluated changes in GABA. Relative to structural markers of injury (e.g., N-acetylaspartate and choline-containing compounds 16 ), GABA is unique in that levels have been shown to be associated with cognitive functioning. For example, correlation of magnetoencephalographymeasures of gamma band activity (likely mediated by GABAa 17 ), fMRI, and GABA was demonstrated in the visual cortex in response to a visual discrimination tasks. 18, 19 Similar findings have been found for motor control and GABA in the supplementary motor area, 20 tactile discrimination and GABA in the sensorimotor cortex, 21 and gaze shifting and GABA levels in the frontal eye fields. 22 In 2 of these studies, control regions, chosen to assess cortical GABA levels remote from the site of interest, demonstrated no concordance to performance. 21, 22 Although GABA level changes do no incorporate measurement of other factors (e.g., receptor density changes, enzyme alterations), the concordance between GABA and discrete task performance supports the need to evaluate this biomarker in conditions in which structural changes may be difficult to characterize.
Evidence on a cellular level also supports that GABA may be a particularly important marker of injury and recovery in concussion. Alterations in GA-BA, especially GABA transport, have been seen in trauma models, both fluid percussion injury 23 and shear injury to the developing brain. 24 GABAmediated inhibition can increase after injury such as stroke in response to transport and receptor dysregulation, and the corresponding increase in tonic inhibition may be deleterious to recovery from injury. 25 Intervention, by pharmacologic inhibition of specific GABA subunits, improved motor function recovery in an animal model. 25 This is a proposed mechanism for impaired recovery after cortical injury, with pharmacologic interventions potentially available to reverse this process. 26 GABA changes may alter postconcussive motor plasticity. 27 However, excessive impairment in GABA can also lead to deleterious effects such as seizures, and the understanding of the complexities of GABA after injury is critical to guiding future interventions. 28 It is plausible that our finding of elevated GABA is imaging evidence of changes known to occur with cellular injury. 23, 24, 28 The selective change in the frontal lobe would be consistent with the increased vulnerability of this region to traumatic injury. The potential that GABA provides a protective effect or corresponds to the postconcussive cognitive symptoms or impairment often observed remains unresolved from this work. While no child in the study was experiencing headaches that would be classified as migraines, literature supporting GABA elevations in this condition provides interesting fodder for consideration. 29 If elevated GABA occurs as a byproduct of injury, it could be envisioned to influence local activity. In general, elevated GABA is associated with improved tuning and performance, suggesting that GABA elevation could be the result of recovery attempts or possibly increased cognitive effort to perform the task as well as healthy controls. Somewhat concordant with this idea, increased activation in the frontal lobe has been described after injury or in impaired states. 30 The correlation between GABA and fMRI activation has been studied, 21, [31] [32] [33] with how well abnormal tissue fits these associations not known. Our GABA voxels included areas outside the strongest activation, but we did find a GABA/fMRI ratio in the frontal lobe that was consistent across the healthy control sample and much higher, and varied, in the concussion group. Elevated GABA was not seen in the other area studied, the medial parietal lobe. Thus, there is some selectivity to the GABA elevation, suggesting that it is related to the function of this brain region or perhaps the task load being applied. This seems possible but, without differences in behavioral performance between groups, premature to conclude. Whether the GABA elevation is causal or only indirectly associated with postconcussive symptoms, it may provide an objective measure for following disease progression and offering a target for modulation.
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